The typical presentation of PRKN-PD is characterised by an early age at onset, usually before 45, a pure motor disease with an excellent response to dopaminergic therapy, slow progression, and a lack of cognitive decline6–9. The gene discussed is PRKN; the disease is Parkinson disease.